Ablation of CFRP Modified with Copper and Calcium Hydroxyapatites by Femtosecond Laser Pulses for Further Material Cutting and Milling Applications.

Paulius Šlevas, Orestas Ulčinas, Sergej Orlov, Egidijus Vanagas, Anna Bilousova, Denys Baklan, Oleksiy Myronyuk

Abstract read

In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Paulius ŠlevasCoherent Optics Laboratory, Optoelectronics Department, Center for Physical Sciences and Technology, Sauletekio Ave. 3, LT-10257 Vilnius, Lithuania.ORCID 0000-0002-9280-5919

Orestas UlčinasCoherent Optics Laboratory, Optoelectronics Department, Center for Physical Sciences and Technology, Sauletekio Ave. 3, LT-10257 Vilnius, Lithuania.

Sergej OrlovCoherent Optics Laboratory, Optoelectronics Department, Center for Physical Sciences and Technology, Sauletekio Ave. 3, LT-10257 Vilnius, Lithuania.ORCID 0000-0003-1692-0189

Egidijus VanagasCoherent Optics Laboratory, Optoelectronics Department, Center for Physical Sciences and Technology, Sauletekio Ave. 3, LT-10257 Vilnius, Lithuania.ORCID 0000-0001-9812-6303

Anna BilousovaDepartment of Chemical Technology of Composite Materials, Chemical Technology Faculty, Igor Sikorsky Kyiv Polytechnic Institute, Beresteiskyi Ave. 37, 03056 Kyiv, Ukraine.ORCID 0000-0002-2818-8450

Denys BaklanDepartment of Chemical Technology of Composite Materials, Chemical Technology Faculty, Igor Sikorsky Kyiv Polytechnic Institute, Beresteiskyi Ave. 37, 03056 Kyiv, Ukraine.ORCID 0000-0002-6608-0117

Oleksiy MyronyukDepartment of Chemical Technology of Composite Materials, Chemical Technology Faculty, Igor Sikorsky Kyiv Polytechnic Institute, Beresteiskyi Ave. 37, 03056 Kyiv, Ukraine.ORCID 0000-0003-0499-9491

Funding

Ministry of Education and Science M/50-2024Research Council of Lithuania P-LU-24-46

6 · The paper itself

Abstract

The interaction of femtosecond laser ultrashort pulses with carbon fiber-reinforced polymer (CFRP) based on epoxy resin modified with different ratios of copper hydroxyapatite (Cu-HAp) and calcium hydroxyapatite (Ca-HAp) was investigated. Ablation efficiency was examined for two CFRP groups containing 1 wt% and 5 wt% Cu-HAp in the epoxy matrix, and in both cases, the maximum ablation efficiency was obtained at a fluence of about 6.4-7.5 J/cm2. The corresponding energy-specific volumes were slightly higher for 1 wt% Cu-HAp (6.95 μm

Indexed as

ablationcarbon fiberCFRPcopper and calcium hydroxyphosphatescuttinglaser processing

Identifiers

PMID42280497

DOI10.3390/polym18111284

PMCPMC13259318

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.